AgaMatrix Raises Series C

AgaMatrix Inc., a Salem, N.H.-based maker of WaveSense blood glucose monitoring products, has raised $23.66 million in Series C funding, according to a regulatory filing. Return backers include Notable International Ltd. and Collaborative Seed & Growth Partners, while VentureWire reports that the round was led by new investor Ferrer Freeman & Co.